Bridgeway Capital Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Buy |
128,617
+22,200
| +21% | +$36.6K | 0.01% | 951 |
|
|
2025
Q1 | $142K | Buy |
106,417
+14,100
| +15% | +$18.8K | ﹤0.01% | 988 |
|
|
2024
Q4 | $173K | Buy |
92,317
+3,822
| +4% | +$7.15K | ﹤0.01% | 1034 |
|
|
2024
Q3 | $68.7K | Sell |
88,495
-50,000
| -36% | -$38.8K | ﹤0.01% | 1193 |
|
|
2024
Q2 | $104K | Hold |
138,495
| – | – | ﹤0.01% | 1161 |
|
|
2024
Q1 | $147K | Hold |
138,495
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q4 | $145K | Hold |
138,495
| – | – | ﹤0.01% | 1191 |
|
|
2023
Q3 | $155K | Buy |
138,495
+83,495
| +152% | +$93.5K | ﹤0.01% | 1142 |
|
|
2023
Q2 | $82.8K | Sell |
55,000
-55,000
| -50% | -$82.8K | ﹤0.01% | 1282 |
|
|
2023
Q1 | $172K | Hold |
110,000
| – | – | ﹤0.01% | 1130 |
|
|
2022
Q4 | $70.1K | Hold |
110,000
| – | – | ﹤0.01% | 1259 |
|
|
2022
Q3 | $146K | Buy |
+110,000
| New | +$146K | ﹤0.01% | 1205 |
|